Voloridge Investment Management
SANA icon

Voloridge Investment Management’s Sana Biotechnology SANA Stock Holding History

Voloridge Investment Management’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-293,159
Closed -$478K – 1347
2024
Q4 		$478K Sell
293,159
-156,662
-35% -$467K ﹤0.01% 1102
2024
Q3 		$1.87M Sell
449,821
-166,766
-27% -$876K 0.01% 945
2024
Q2 		$3.37M Buy
+616,587
New +$4.91M 0.01% 850
2023
Q4 		– Sell
-88,067
Closed -$341K – 1435
2023
Q3 		$341K Sell
88,067
-18,159
-17% -$97.6K ﹤0.01% 1262
2023
Q2 		$633K Buy
+106,226
New +$612K ﹤0.01% 1199

Other funds holding SANA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Voloridge Investment Management's SANA Position: Q1 2025 in Review

Voloridge Investment Management sold out of Sana Biotechnology (SANA) in Q1 2025, closing a stake of 293,159 shares — an estimated $478K sold.

Voloridge Investment Management first reported a position in SANA in Q2 2023 and held it in 5 quarters. The position peaked at $3.37M in Q2 2024. 161 funds tracked by Wall St. Rank hold SANA as of Q1 2025.

  • Voloridge Investment Management reported no remaining Sana Biotechnology position as of Q1 2025 after selling out during the quarter.
  • Voloridge Investment Management sold 293,159 Sana Biotechnology shares in Q1 2025, an estimated $478K.
  • Voloridge Investment Management first reported a position in Sana Biotechnology in Q2 2023 and held it in 5 quarters.
  • Voloridge Investment Management's Sana Biotechnology position peaked at $3.37M in Q2 2024.
  • 161 funds tracked by Wall St. Rank held Sana Biotechnology as of Q1 2025.

Based on Voloridge Investment Management's 13F filing for Q1 2025, filed 15 May 2025.